Keratin 19 demonstration of canal of hering loss in primary biliary cirrhosis: "Minimal Change PBC"?

Hepatology

Volumn 57, Issue 2, 2013, Pages 700-707

  Khan, Fahad M ^a   Komarla, Arathi Rajendra ^a   Mendoza, Paulo G ^a   Bodenheimer, Henry C ^a   Theise, Neil D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; CYTOKERATIN 19; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN M; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; MINIMAL CHANGE PRIMARY BILIARY CIRRHOSIS; OUTCOME ASSESSMENT; PORTAL VEIN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; BILE DUCTS, INTRAHEPATIC; BIOPSY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-19; LIVER; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; PROSPECTIVE STUDIES; URSODEOXYCHOLIC ACID;

EID: 84873301884     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26020     Document Type: Article

References (21)

1. Lee YM, Kaplan MM. The natural history of PBC: has it changed? Semin Liver Dis 2005; 25: 321-326.
2. Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol 2010; 52: 745-758.
3. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ; American Association for Study of Liver Diseases. Primary biliary cirrhosis. HEPATOLOGY 2009; 50: 291-308.
4. Saxena R, Hytiroglou P, Thung SN, Theise ND. Destruction of canals of Hering in primary biliary cirrhosis. Hum Pathol 2002; 33: 983-988.
5. Theise ND, Saxena R, Portmann BP, Thung SN, Yee H, Chiriboga L Kumar A, et al. The canals of hering and hepatic stem cells in humans. HEPATOLOGY 1999; 30: 1425-1433.
6. Saxena R, Theise ND. Canals of Hering: recent insights and current knowledge. Semin Liver Dis 2004; 24: 43-48.
7. Zhang L, Theise ND, Chua M, Reid LM. The stem cell niche of human livers: symmetry between regeneration and development. HEPATOLOGY 2008; 48: 1598-1607.
8. Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: a quantitative reference standard. HEPATOLOGY 1998; 28: 323-331.
9. Theise ND, Bodenheimer H, Ferrell L. Viral hepatitis. In: Burt AD, Portmann BC, Ferrell LD, eds. MacSween's Pathology of the Liver, 6th ed. London: Saunders; 2010.
10. Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000; 174: 210-225.
11. Chatzipantelis P, Lazaris AC, Kafiri G, Papadimitriou K, Papathomas PG, Nonni A, et al. Cytokeratin-7, cytokeratin-19, and c-Kit: Immunoreaction during the evolution stages of primary biliary cirrhosis. Hepatol Res 2006; 36: 182-187.
12. Jorgensen RA, Dickson ER, Hofmann AF, Rossi SS, Lindor KD. Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. Gut 1995; 36: 935-938.
13. Goodman ZD, McNally PR, Davis DR, Ishak KG. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 1995; 40: 1232-1242.
14. Oertelt S, Rieger R, Selmi C, Invernnizi P, Ansari AA, Copppel RL, et al. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. HEPATOLOGY 2007; 45: 659-665.
15. Gisbert JP, Jones EA, Pajares JM, Moreno-Otero R. Review article: is there an optimal therapeutic regimen for antimithochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)? Aliment Pharmacol Ther 2003; 17: 17-27.
16. Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. HEPATOLOGY 2001; 34: 243-248.
17. Poupon R, Chazouilleres O, Corpechot C, Chrétien Y. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis. HEPATOLOGY 2006; 44: 85-90.
18. Elta GH, Sepersky RA, Goldberg MJ, Connors CM, Miller KB, Kaplan MM. Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig Dis Sci 1983; 28: 971-975.
19. Sakauchi F, Mori M, Zeniya M, Toda G. Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol 2006; 16: 30-34.
20. Kuwahara R, Kofman AV, Landis CS, Swenson ES, Barendswaard E, Theise ND. The hepatic stem cell niche: identification by label retaining cell assay. HEPATOLOGY 2008; 47: 1994-2002.
21. Yoon SM, Gerasimidou D, Kuwahara R, Hytiroglou P, Yoo E, Park YN, et al. Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. HEPATOLOGY 2011; 53: 964-973.